News
1d
Zacks Investment Research on MSNVeeva vs. Salesforce: Which Life Sciences CRM Stock Is the Better Buy?A significant shift is underway in the enterprise software landscape, particularly within the life sciences customer relationship management (CRM) market. Veeva Systems VEEV, a long-time partner of ...
Salesforce, Inc. (NYSE:CRM) is one of the 12 stocks that will make you rich in 10 years. On June 23, the company announced an enhanced collaboration with PayPal (NASDAQ:PYPL) through the ...
NEW YORK – Salesforce.com recently reported first-quarter results showing growth of more than 80 percent in its paid-subscribers count and revenue from the year-ago period, then followed that ...
Let me also elaborate by giving a few reasons why Salesforce may not be your best CRM option, particularly if you’re a small business. The first reason is that Salesforce is not a small business ...
Scott Berg, an analyst at Needham, gave Salesforce Inc.’s (NYSE:CRM) acquisition of Informatica a thumbs-up on May 28, reiterating his Buy rating and keeping his price target intact at $400.
VitalPBX launches a seamless Salesforce CRM integration, empowering contact centers with real-time insights, and enhanced customer service capabilities. This integration redefines how contact ...
In our 2025 Salesforce review, we'll take a close look at the features, pros, and cons of this popular CRM platform so you can decide if it's right for your needs and budget.
VitalPBX launches a seamless Salesforce CRM integration, empowering contact centers with real-time insights, and enhanced customer service capabilities. This integration redefines how contact ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results